Quantbot Technologies LP Sells 17,008 Shares of Maximus, Inc. $MMS

Quantbot Technologies LP lessened its holdings in Maximus, Inc. (NYSE:MMS) by 38.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 26,855 shares of the health services provider’s stock after selling 17,008 shares during the period. Quantbot Technologies LP’s holdings in Maximus were worth $2,454,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Norges Bank acquired a new position in shares of Maximus in the second quarter valued at $47,886,000. Boston Partners boosted its holdings in shares of Maximus by 113.6% during the 2nd quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock worth $46,435,000 after buying an additional 349,529 shares during the period. River Road Asset Management LLC bought a new stake in shares of Maximus during the 2nd quarter worth about $18,073,000. Stephens Investment Management Group LLC grew its stake in Maximus by 49.0% in the 3rd quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock valued at $65,873,000 after buying an additional 237,097 shares during the last quarter. Finally, Voya Investment Management LLC raised its holdings in Maximus by 1,380.3% in the 3rd quarter. Voya Investment Management LLC now owns 228,488 shares of the health services provider’s stock valued at $20,877,000 after acquiring an additional 213,053 shares during the period. 97.21% of the stock is owned by institutional investors.

Insider Transactions at Maximus

In other news, CEO Bruce Caswell acquired 3,175 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The stock was acquired at an average price of $78.45 per share, with a total value of $249,078.75. Following the completion of the transaction, the chief executive officer directly owned 328,013 shares of the company’s stock, valued at $25,732,619.85. This trade represents a 0.98% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO David Mutryn acquired 1,000 shares of Maximus stock in a transaction on Monday, February 9th. The shares were purchased at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the purchase, the chief financial officer directly owned 40,037 shares of the company’s stock, valued at approximately $3,027,597.94. This represents a 2.56% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 1.80% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. Weiss Ratings lowered Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, February 24th. Finally, Wall Street Zen downgraded Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, Maximus currently has a consensus rating of “Buy”.

Maximus Stock Up 3.0%

Shares of MMS opened at $76.07 on Wednesday. Maximus, Inc. has a 12 month low of $63.80 and a 12 month high of $100.00. The firm’s 50 day moving average is $86.29 and its 200-day moving average is $86.26. The stock has a market capitalization of $4.15 billion, a PE ratio of 11.58 and a beta of 0.59. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.01. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The firm’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. Equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were given a $0.33 dividend. The ex-dividend date was Friday, February 13th. This is an increase from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.7%. Maximus’s dividend payout ratio (DPR) is 20.09%.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.